Immunogen - 株価

IMGN

7.21

毎日の変更:

-4.88%

毎年:

49.28%

価格 日 年
Astellas Pharma 1,662.50 8.00 0.48% -12.98%
AbbVie 110.52 -1.11 -0.99% 23.82%
Agios Pharmaceuticals 45.67 -0.28 -0.61% -11.41%
Amgen 245.49 3.83 1.58% 2.07%
Arena Pharmaceuticals 80.50 -0.06 -0.07% 73.96%
AstraZeneca 7,592.00 33.00 0.44% -1.49%
Bluebird Bio 50.53 -1.32 -2.55% -48.16%
Bristol-Myers Squibb 66.54 0.52 0.79% -0.36%
Cerulean Pharma 1.44 -0.10 -6.49% -11.11%
Dicerna Pharmaceuticals 23.57 -0.78 -3.20% 11.28%
Emergent BioSolutions 106.29 0.30 0.28% 89.67%
Exelixis 23.73 -0.06 -0.23% 16.07%
Five Prime Therapeutics 14.22 -1.74 -10.90% 176.12%
Halozyme Therapeutics 47.43 0.38 0.81% 135.62%
Heron Therapeutics 17.64 -0.70 -3.82% -23.00%
Immunogen 7.21 -0.37 -4.88% 49.28%
Karyopharm Therapeutics 14.94 -0.38 -2.48% -20.66%
Eli Lilly 190.77 4.08 2.19% 34.89%
MacroGenics 20.59 -0.03 -0.15% 77.65%
Nektar Therapeutics 16.98 -0.82 -4.61% -28.95%
Novartis 94.61 0.87 0.92% -0.52%
Pfizer 36.70 -0.05 -0.14% -9.63%
Regeneron Pharmaceuticals 517.93 0.02 0.004% 34.33%
Roche Holding 316.65 4.60 1.47% -1.34%
Seattle Genetics 185.75 9.89 5.62% 72.53%
Sanofi 48.70 0.33 0.67% -4.86%
Acceleron Pharma 126.19 -0.78 -0.61% 124.34%
Intrexon 8.01 -0.60 -6.97% 28.57%

価格 日 年
NASDAQ 12998 -114.13 -0.87% 38.92%
Russell 2000 2123 -32.15 -1.49% 24.51%

IMGN:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
配当率
EBIT
EBITDA
従業員
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者